TARSUS PHARMACEUTICALS INC (TARS:NASDAQ)
$71.76 -0.16 (-0.2225%)
Analysed TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) News Sources
All You Need to Know About Tarsus Pharmaceuticals (TARS) Rating Upgrade to Buy
08-07-2026
yahoo.com
Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth
13-07-2026
yahoo.com
Tarsus Pharmaceuticals (TARS) Replaces Its Commercial Chief While iRenix Talks Continue
16-07-2026
yahoo.com
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
06-08-2026
yahoo.com
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
06-08-2026
yahoo.com
Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M
06-08-2026
biopharmadive.com
Tarsus joins Stargardt race to market with $800m Alkeus takeover
07-08-2026
pharmaceutical-technology.com
Tarsus Pharmaceuticals Q2 Earnings Call Highlights
07-08-2026
marketbeat.com
Tarsus (TARS) Q2 2026 Earnings Call Transcript
13-08-2026
fool.com
Tarsus Pharmaceuticals (TARS) Stock Looks Reasonable On Sales While Earnings Stay Weak
13-08-2026
yahoo.com
What is the current price of TARSUS PHARMACEUTICALS INC (TARS:NASDAQ)?
The current price of TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) is $71.76.
TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) absolute price change since previous trading day?
The absolute price change of TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) since the previous trading day is $-0.16.
TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) percentage price change since previous trading day?
The percentage price change of TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) since the previous trading day is -0.2225%.
What is the most recent average sentiment score for TARSUS PHARMACEUTICALS INC (TARS:NASDAQ)?
The most recent average sentiment score for TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for TARSUS PHARMACEUTICALS INC (TARS:NASDAQ)?
The most recent sentiment for TARSUS PHARMACEUTICALS INC (TARS:NASDAQ) is .
SEC-8K** Filing Available For TARSUS PHARMACEUTICALS INC (TARS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.